S4098 Bowel Regimen Gone Rogue: A Rare Case of Anaphylaxis Secondary to Over-the-Counter Polyethylene Glycol 3350

Introduction: Polyethylene glycol 3350 (PEG) is a common agent used for bowel preparation before colonoscopy or other lower GI endoscopies. It is also readily available over the counter for constipation. It is generally well-tolerated. Below, we present a case of a patient who had anaphylaxis secondary to PEG. Case Description/Methods: A 57-year-old man with coronary artery disease, hypertension, hyperlipidemia and diabetes presented to the emergency department with hypotension, nausea, and diffuse itchiness 4 hours after taking PEG for preoperative constipation. Within 5 minutes of ingestion, he developed diffuse pruritus and a rash on the arms and legs. He took oral diphenhydramine with minor relief, prompting his emergency department visit. On arrival, he was tachycardic (HR 95), tachypneic (RR 29), and hypotensive (BP 83/58-- > 77/59). Workup showed normal white blood cell count, normal hemoglobin, and normal platelets; however, lactic acid was elevated to 5.6. He was given IV methylprednisolone sodium succinate 125 mg, IV famotidine 20 mg, IV diphenhydramine 25 mg and started on an epinephrine infusion. He was admitted to the ICU where he subsequently recovered. He had surgery a few days later. Discussion: PEG is widely used for bowel preparation, with most patients tolerating it well. It is also frequently prescribed for constipation and is found in more than 1,000 FDA-approved medications, including contraceptives, antihypertensives, antibiotics, and diabetes drugs. A review of literature identified only 53 reports between 2005 and 2017 in which PEG was suspected to be the cause of an anaphylactic reaction with an average of only 4 cases per year from 2005 to 2017. Most reactions occurred during colonoscopy prep, though about ¼ occurred during constipation treatment. While rare, PEG should remain on differential as a cause of anaphylaxis, and alternative bowel regimens should be considered for patients with a history of reaction. Options without polyethylene glycols or polysorbates include sodium picosulfate, magnesium oxide, anhydrous citric acid; sodium phosphate tablets; oral sulfate solution/tablets; magnesium citrate; bisacodyl; and off label lactulose.

Authors

Publication Details

Journal
The American Journal of Gastroenterology
Published
2025-10-01
DOI
https://doi.org/10.14309/01.ajg.0001143852.26289.b0
Primary Topic
Colorectal Cancer Screening and Detection
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

S4098 Bowel Regimen Gone Rogue: A Rare Case of Anaphylaxis Secondary to Over-the-Counter Polyethylene Glycol 3350

Jigisha Srivastav, Corey Williams, Abigail L. Ellington
The American Journal of Gastroenterology
Colorectal Cancer Screening and Detection
article

S4098 Bowel Regimen Gone Rogue: A Rare Case of Anaphylaxis Secondary to Over-the-Counter Polyethylene Glycol 3350

Jigisha Srivastav, Corey Williams, Abigail L. Ellington
article en

Abstract

Introduction: Polyethylene glycol 3350 (PEG) is a common agent used for bowel preparation before colonoscopy or other lower GI endoscopies. It is also readily available over the counter for constipation. It is generally well-tolerated. Below, we present a case of a patient who had anaphylaxis secondary to PEG. Case Description/Methods: A 57-year-old man with coronary artery disease, hypertension, hyperlipidemia and diabetes presented to the emergency department with hypotension, nausea, and diffuse itchiness 4 hours after taking PEG for preoperative constipation. Within 5 minutes of ingestion, he developed diffuse pruritus and a rash on the arms and legs. He took oral diphenhydramine with minor relief, prompting his emergency department visit. On arrival, he was tachycardic (HR 95), tachypneic (RR 29), and hypotensive (BP 83/58-- > 77/59). Workup showed normal white blood cell count, normal hemoglobin, and normal platelets; however, lactic acid was elevated to 5.6. He was given IV methylprednisolone sodium succinate 125 mg, IV famotidine 20 mg, IV diphenhydramine 25 mg and started on an epinephrine infusion. He was admitted to the ICU where he subsequently recovered. He had surgery a few days later. Discussion: PEG is widely used for bowel preparation, with most patients tolerating it well. It is also frequently prescribed for constipation and is found in more than 1,000 FDA-approved medications, including contraceptives, antihypertensives, antibiotics, and diabetes drugs. A review of literature identified only 53 reports between 2005 and 2017 in which PEG was suspected to be the cause of an anaphylactic reaction with an average of only 4 cases per year from 2005 to 2017. Most reactions occurred during colonoscopy prep, though about ¼ occurred during constipation treatment. While rare, PEG should remain on differential as a cause of anaphylaxis, and alternative bowel regimens should be considered for patients with a history of reaction. Options without polyethylene glycols or polysorbates include sodium picosulfate, magnesium oxide, anhydrous citric acid; sodium phosphate tablets; oral sulfate solution/tablets; magnesium citrate; bisacodyl; and off label lactulose.

The American Journal of GastroenterologyVol. 120(10S2)
Openalex Percentile: Top 54%
Colorectal Cancer Screening and Detection
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

S4098 Bowel Regimen Gone Rogue: A Rare Case of Anaphylaxis Secondary to Over-the-Counter Polyethylene Glycol 3350 — Jigisha Srivastav, Corey Williams, et al. · The American Journal of Gastroenterology (2025) | TGRS Research Map | TGRS